Fairvalue-Calculator Fairvalue-Calculator
EN DE

Alembic Pharmaceuticals Limited (APLLTD) Fair Value & Analysis

Healthcare · IN · Market cap ₹151B

Price₹771.50
Fair Value₹629.38
Upside-18.4%
Quality97/100
Evidence: High Range ₹355.53 – ₹802.33

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Alembic Pharmaceuticals Limited (APLLTD) currently trades at ₹771.50, while our model-based Fair Value estimate is ₹629.38 — implying the stock looks roughly 18.4% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81% Swedish Orphan Biovitrum AB (SOBI) -1%

Frequently asked questions

Is Alembic Pharmaceuticals Limited (APLLTD) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹629.38 versus a price of ₹771.50 — about −18% (overvalued). Model-based estimate, not financial advice.
What is the fair value of APLLTD?
Our 21-model fair value for Alembic Pharmaceuticals Limited is ₹629.38 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹771.50.
What is the quality score of APLLTD?
Alembic Pharmaceuticals Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.